ISRCTN12125882已完成不适用
Influence of topical anti-VEGF (Ranibizumab) on the outcome of filtration surgery for glaucoma: A two phased study with a randomised placebo controlled trial
Horten Center, University of Zurich (Switzerland)0 个研究点目标入组 50 人开始时间: 2010年8月18日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Patients with primary open angle glaucoma (POAG), PEX and pigment dispersion Glaucoma
- •2. At least 18 years of age
- •3. No previous intraocular surgery undergoing trabeculectomy or phaco-trabeculectomy
排除标准
- •1. Patients with primary angle closure glaucoma (PACG)
- •2. Glaucoma due to other causes
- •3. Previous intra- and extraocular surgery
- •4. Any surgery during the last 3 months
- •5. Patients with uveitis or inflammatory ocular surface disease
- •6. Patients with single eyes
- •7. Patients presenting the first postoperative day with bleb leak, hypotony or situations that potentially need another surgery
- •8. Pregnant and breast feeding women
- •9. Women planning to get pregnant
研究者
相似试验
已完成
不适用
The efficacy of topical NSAIDs for anti-VEGF therapy for vitreomacular diseaseretinal vein occlusion diabetic retinopathy age related macular degenerationJPRN-UMIN000014929TT East japan Tohoku Hospital200
已完成
不适用
Anti-VEGF (bevacizumab/ranibizumab) versus RPE-choroid graft in the treatment of 1) non-responders to 3 intravitreal anti-VEGF injections, or 2) patients with AMD and pigment epithelium rip, or 3) patients with AMD and massive haemorrhage. A randomized trial.Exudative age-related macular degeneration in combination with either 1) visual loss of ¡Ý 15 letters on the ETDRS chart after 3 anti-VEGF injections, 2) subfoveal RPE-tear, or 3) massive submacular haemorrhage.NL-OMON29614Oogziekenhuis Rotterdam (OZR)240
招募中
不适用
The effect of anti-VEGF treatments for neovascular,exudative and inflammatory ocular diseasesOcular diseases including neovascular, serous and inflammatory diseasesJPRN-UMIN000021589The department of ophthalmology,Tohoku university graduate School of Medicine3,000
进行中（未招募）
1 期
IMPACT OF ANTI-TNF, VEDOLIZUMAB AND TOFACITINIB ON AORTIC STIFFNESS, CAROTID INTIMA-MEDIA THICKNESS AND CARDIOVASCULAR RISK OF PATIENTS WITH ULCERATIVE COLITISulcerative colitisEUCTR2020-004391-18-FRCHU Amiens-Picardie100
已完成
3 期
Anti-VEGF (bevacizumab/ranibizumab) versus RPE-choroid graft in the treatment of 1) non-responders to 3 intravitreal anti-VEGF injections, or 2) patients with AMD and pigment epithelium rip, or 3) patients with AMD and massive haemorrhage. A randomized trial.age-relatede macular degeneration10047060NL-OMON33994Oogziekenhuis Rotterdam40